Please login to the form below

Not currently logged in
Email:
Password:

Pharma news in brief

Our weekly round-up of the news in brief

EU should get tough on counterfeits
Tougher measures must be introduced in the European Union to stamp out trading of counterfeit drugs, according to a new report from Professor David Taylor from the University of London School of Pharmacy. Professor Taylor said that while the problem had originally been concentrated in developing countries, the global nature of the pharma industry means that patients everywhere are now at risk. In his report, which was launched at the House of Commons on November 29, he noted that the increased rationing of drugs could fuel the practice of counterfeiting. He has called for tougher legal penalties and better control of internet pharmacies, suggesting that because parallel trade, while not illegal, is difficult to monitor, it is attractive to counterfeiters. The report was funded by a grant from Pfizer.

HIV/AIDS drugs should be available in the workplace
The International Labour Organisation, part of the United Nations, has said that the workplace could offer the best setting to administer anti-retroviral (ARVs) drugs to people with HIV/AIDS. In a report published on World AIDS Day, the agency said that more than 24 million people in the global workforce in 2005 had HIV/AIDS, with 67 per cent living in Africa. The agency believes that ARVs should be made available in the workplace, estimating that 1.8 million more Africans could be alive in 2010 if 80 per cent of the workforce were treated with them.

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics